IL-23, produced by dendritic cells (DCs) and macrophages, plays a critical role in innate immunity against bacterial infection. Our previous studies show that morphine disrupts the IL-23/IL-17 mediated pulmonary mucosal host defense and increases susceptibility to Streptococcus pneumoniae lung infection. To determine the mechanism by which morphine modulates IL-23 production, mouse bone marrow-derived dendritic cells (BMDCs) and macrophages (BMDMs) were treated with morphine, and infected with S. pneumoniae or stimulated with Toll-like receptor (TLR) and Nod2 ligands. We found that a significant increase in IL-23 protein production was observed in S. pneumoniae, TLR2 ligand lipoteichoic acid (LTA), and TLR4 ligand pneumolysin (PLY) stimulated BMDCs and BMDMs. Interestingly, although Nod2 ligand muramyldipeptide (MDP) alone had no effect on IL-23 production, it potentiated LTA induced IL-23 production to the same level as that observed following S. pneumoniae infection, suggesting that S. pneumoniae induced IL-23 production in DCs involves activation of both TLR2 and Nod2 signaling mechanisms. Furthermore, pretreatment of DCs with MyD88 (myeloid differentiation primary response gene 88) and IL-1 receptor-associated kinase (IRAK) 1/4 inhibitors, or TLR2 antibody diminished the S. pneumoniae induced IL-23 and abolished the inhibitory effects of morphine, indicating that S. pneumoniae induced IL-23 production depends on activation of the TLR2-MyD88-IRAK1/4 signaling pathway. Moreover, morphine decreased S. pneumoniae induced phosphorylation of interferon regulatory factor 3 (IRF3) and activating transcription factor 2 in DCs. Taken together, our study shows that morphine impairs S. pneumoniae induced IL-23 production through MyD88-IRAK1/4-dependent TLR2 and Nod2 signaling in DCs.Host innate immune defenses in the airways, in most cases, efficiently clear invading Streptococcus pneumoniae and thereby prevent bacterial entry into the lungs and dissemination into the bloodstream. However, any compromise in the host innate immune function increases the risk of bacterial invasion resulting in pneumococcal disease (1, 2). Our previous studies show that morphine impairs host innate immune response and increases susceptibility to S. pneumoniae lung infection (3, 4). Furthermore, our current study show that chronic morphine disrupts the IL-23/IL-17 mediated pulmonary mucosal host defense against S. pneumoniae lung infection in an in vivo murine pulmonary S. pneumoniae infection model and in an in vitro cell infection model (5). However, the cellular and molecular mechanisms by which morphine modulates S. pneumoniae induced IL-23 production remain to be elucidated.Resident lung phagocytic cells, primarily dendritic cells and alveolar macrophages, are likely the first immune cells exposed to S. pneumoniae upon inhalation of the organism into the lungs. Dendritic cells and alveolar macrophages express various pattern recognition receptors such as Toll-like receptors (TLRs) 4 and Nod (nucleotide-binding oligomerization domain) r...